APOA1 and coronary atherosclerosis: In patients not using LLM, a high level of apoA-I identified with the antibody pair 110–525 was associated with the presence of coronary atherosclerosis; however, HDL-C and apoA-I levels measured using a polyclonal anti-apoA-I-based ELISA test were not.